Is BTTX or GBDC a better dividend investment in 2026?

BTTX currently yields 2000000.00% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: BTTX offers higher current income.

What is the dividend yield difference between BTTX and GBDC?

BTTX has a forward dividend yield of 2000000.00% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 1999988.14 percentage points.

Home › Compare › BTTX vs GBDC

BTTX vs GBDC: Dividend Comparison 2026

BTTX yields 2000000.00% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BTTX wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BTTX

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full BTTX calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — BTTX vs GBDC

📍 BTTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BTTX	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BTTX + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BTTX pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BTTX

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, BTTX beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BTTX + GBDC for your $10,000?

BTTX: 50%GBDC: 50%

100% GBDC50/50100% BTTX

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

BTTX

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-27.3

Piotroski

2/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BTTX buys

GBDC buys

No recent congressional trades found for BTTX or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBTTXGBDC

Forward yield	2000000.00% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$4.879226400974806e+39M	$20.85M ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$16,450,733.83
Total dividends collected	$4.879195005460081e+39M	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC
Analyst consensus	Buy	Buy

Year-by-year: BTTX vs GBDC ($10,000, DRIP)

Year	BTTX Portfolio	BTTX Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$12,492	$1,791.70	+$200.00M → BTTX
2	$3,738,731,768,458	$3,738,517,757,009.35	$16,527	$3,160.58	+$3738731.75M → BTTX
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$23,588	$5,904.90	+$65315062866.91M → BTTX
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$37,141	$11,901.65	+$1066400830062625.00M → BTTX
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$66,205	$26,463.38	+$16272182796453826560.00M → BTTX
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$137,452	$66,612.65	+$2.3205424011366188e+23M → BTTX
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$342,372	$195,298.53	+$3.0927990661046884e+27M → BTTX
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$1,053,292	$686,954.33	+$3.8524105697352695e+31M → BTTX
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$4,111,439	$2,984,416.95	+$4.484688260147987e+35M → BTTX
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$20,849,974	$16,450,733.83	+$4.879226400974806e+39M → BTTX

BTTX vs GBDC: Complete Analysis 2026

BTTX — Stock

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.

Full BTTX Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this BTTX vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BTTX vs SCHD BTTX vs JEPI BTTX vs O BTTX vs KO BTTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.